Relation of Body Mass Index to Mortality Among Men With Coronary Heart Disease

被引:39
作者
Benderly, Michal [1 ,2 ,3 ]
Boyko, Valentina [2 ]
Goldbourt, Uri [1 ,3 ]
机构
[1] Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, Israel Soc Prevent Heart Attacks, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Res Policy, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel
关键词
MYOCARDIAL-INFARCTION; OBESITY PARADOX; ARTERY-DISEASE; WEIGHT-CHANGE; RISK; TERM; GUIDELINES; IMPACT;
D O I
10.1016/j.amjcard.2010.03.078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reports among patients with coronary heart disease regarding the association between body mass index (BMI) and long-term mortality are inconsistent, ranging among linear, U-shaped, or inverse (the "obesity paradox") associations. BMI and mortality data were available for 12,466 men with chronic coronary heart disease. BMI was classified as <20 (lean), 20.0 to 22.99, 23.0 to 24.99 (reference), 25.0 to 26.99, 27.0 to 29.99, and >= 30 kg/m(2) (obese). Age-adjusted (direct methods) mortality was investigated within risk factor categories. Adjusted hazard ratios compared with the reference group were estimated using a Cox proportional-hazards model. Two thirds of the patients had BMIs >= 25 kg/m(2). A number of risk factors were progressively more frequent with increasing BMI (age, diabetes, past smoking, and metabolic components). Over a median follow-up period of 12 years, adjusted mortality rates per 1,000 patient-years followed a U-shaped association with BMI. The highest risk was noted in 148 lean (hazard ratio 1.41, 95% confidence interval 1.08 to 1.85) and 1,788 obese (hazard ratio 1.28, 95% confidence interval 1.15 to 1.42) patients. Mortality hazard in patients with BMIs of 20.0 to 29.99 kg/m(2) (84% of patients) did not significantly differ from the reference group (lowest risk). Risk factor presence was associated with higher mortality in every BMI category. Lean patients had a particularly poor prognosis in the presence of past myocardial infarction, smoking, or renal insufficiency. A U-shaped association was found in most subgroups examined. In conclusion, BMI >= 25 kg/m(2) is common in patients with coronary heart disease. A U-shaped association, with highest risk among lean and obese patients, is persistent regardless of risk factor presence. Further data are required to support the need of aggressive weight reduction in patients with BMIs <30 kg/m(2). (C) 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106: 297-304)
引用
收藏
页码:297 / 304
页数:8
相关论文
共 26 条
  • [1] The syndrome of cardiac cachexia
    Anker, SD
    Sharma, R
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 85 (01) : 51 - 66
  • [2] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword
    Eknoyan, G
    Levin, NW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : S14 - S266
  • [3] Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor
    Ellat-Adar, S
    Eldar, M
    Goldbourt, U
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (04) : 352 - 358
  • [4] The Obesity Paradox in Patients With Peripheral Arterial Disease
    Galal, Wael
    van Gestel, Yvette R. B. M.
    Hoeks, Sattne E.
    Sin, Don D.
    Winkel, Tamara A.
    Bax, Jeroen J.
    Verhagen, Hence
    Awara, Adel M. M.
    Klein, Jan
    van Domburg, Ron T.
    Poldermans, Don
    [J]. CHEST, 2008, 134 (05) : 925 - 930
  • [5] Relation of body mass index, to outcome in patients with known or suspected coronary artery disease
    Galal, Wael
    van Domburg, Ron T.
    Feringa, Harm H. H.
    Schouten, Olaf
    Elhendy, Abdou
    Bax, Jeroen J.
    Awara, Adel M. M.
    Klein, Jan
    Poldermans, Don
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11) : 1485 - 1490
  • [6] RATIONALE AND DESIGN OF A SECONDARY PREVENTION TRIAL OF INCREASING SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND REDUCING TRIGLYCERIDES IN PATIENTS WITH CLINICALLY MANIFEST ATHEROSCLEROTIC HEART-DISEASE (THE BEZAFIBRATE INFARCTION PREVENTION TRIAL)
    GOLDBOURT, U
    BEHAR, S
    REICHERREISS, H
    AGMON, J
    KAPLINSKY, E
    GRAFF, E
    KISHON, Y
    CASPI, A
    WEISBORT, J
    MANDELZWEIG, L
    ABINADER, E
    AHARON, L
    BRAUN, S
    DAVID, D
    FLICH, M
    FRIEDMAN, Y
    KRISTAL, N
    LEIL, N
    MARKIEWICZ, W
    MARMOR, A
    PALANT, A
    PELLED, B
    RABINOWITZ, B
    REISIN, L
    ROGUIN, N
    ROSENFELD, T
    SCHLESINGER, Z
    SCLAROVSKY, S
    SHERF, L
    TZIVONI, D
    ZAHAVI, I
    ZION, M
    BRUNNER, D
    FRIDENSOHN, A
    JAFARI, J
    OSTFELD, B
    ROCHFLEISH, S
    SCHNEIDER, H
    KHALID, S
    NARINSKY, R
    ROTZAK, R
    VITRAI, J
    PELLED, B
    PARDU, J
    LANIADO, S
    ESHCHAR, Y
    ARDITI, A
    BOTWIN, S
    ROGUIN, N
    YAHALOM, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (11) : 909 - 915
  • [7] The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization - Insights from the Bypass Angioplasty Revascularization Investigation (BAPI)
    Gurm, HS
    Whitlow, PL
    Kip, KE
    BARI Invest
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 834 - 840
  • [8] The obesity paradox: Fact or fiction?
    Habbu, Amit
    Lakkis, Nasser M.
    Dokainish, Hisham
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (07) : 944 - 948
  • [9] Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
  • [10] 2-4